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Abstract. Calcifications are one of the most important indicators for early breast cancer detection. We explore the
feasibility of deep-penetration photoacoustic (PA) imaging of calcifications based on a medical ultrasound array
imaging platform. Intralipid and chicken breast phantoms embedded with different-sized hydroxyapatite (HA) par-
ticles, which are the major components of calcifications, were imaged to verify the equipment’s capability and
penetration depth for the visualization of calcifications. An optimal near-infrared excitation wavelength was
selected to maximize PA signals of HAs, resulting in a better HA signal-to-blood ratio. We demonstrated that
PA imaging is capable of visualizing 0.5-mm HA particles at a depth of 3 cm in chicken breast phantoms. The
noise-equivalent penetration depth of the system for visualizing 0.5-mm HA particles in the human breast was
estimated to be about 2.9 to 3.5 cm, which is clinically relevant as calcifications are usually found at a depth
of 0.6 to 3.0 cm. Moreover, the feasibility of differentiating HA from blood by the PA spectroscopic technique
was presented and the mechanism of the HA signal generation was discussed. The results show that PA imaging
is a promising technique for real-time visualization of breast calcifications. © 2013 Society of Photo-Optical Instrumentation
Engineers (SPIE) [DOI: 10.1117/1.JBO.18.6.066002]
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1 Introduction
In x-ray mammography, the size, number, and clustering of
microcalcifications are important features for grading the suspi-
cious lesions based on BI-RADS classification scale.1 Currently,
x-ray mammography is the standard for breast cancer screening;
however, its use exposes patients to the carcinogenic risks of
ionizing radiation. Ultrasound is recommended as the appropri-
ate modality for the evaluation of palpable breast masses. One
challenge is the difficulty of imaging calcifications smaller than
1 mm due to poor contrast resulting from inherent speckle
noise.2 Therefore, a new modality that combines the calcifica-
tion imaging capabilities of x-ray mammography and the non-
ionization feature of ultrasound is warranted. Photoacoustic
(PA) imaging is an emerging imaging modality capable of
real-time, nonradioactive, and high-resolution optical imaging
of tissues with deep penetration. Among the various PA
imaging techniques investigated to date, near-infrared (NIR)
PA imaging of angiogenesis is of particular interest for noninva-
sive breast diagnosis because of the high absorption contrast
between hemoglobin and other breast tissues.3,4 Using a cus-
tom-made 10-MHz photoacoustic microscopy (PAM) setup,
we have demonstrated the feasibility of using PA imaging for
high-contrast visualization of calcifications, which may poten-
tially be utilized as an auxiliary tool to conventional breast ultra-
sound and x-ray mammography.5 At a depth of 2 mm, the PA
signal of 0.5 mm granulated hydroxyapatite (HA)—a major
chemical composition of breast calcifications associated with
malignant and benign lesions6—rivals that of blood, the dom-
inant optical absorber, at a wavelength of 750 nm. Recently,
Kang et al. have also validated the use of PA imaging of calci-
fications within core-biopsied breast tissue of 3.5 mm thickness
by shining a laser directly onto the sample.7 The calcification
imaging systems presented in these studies show limited pen-
etration depth and are not sufficient for diagnosis and biopsy
guidance. Although Song and Wang have demonstrated that
a PAM-like setup, using a 5-MHz single-element transducer
with long focal depth, can provide penetration up to 38 mm
in a chicken breast phantom for imaging of blood content,8
real-time imaging capability and extended depth of focus with
dynamic receive focusing technique are not feasible. Both fea-
tures are required for real-time diagnosis and biopsy guidance,
which can be provided with an array imaging system.
Therefore, in this study, we investigate the feasibility of
deep-penetration PA imaging based on a medical ultrasound
array imaging platform to visualize calcifications. First, an opti-
mal excitation wavelength was selected to maximize the PA sig-
nals from HA particles and to optimize the ratio of HA to blood
signal, in order to reduce the interference of blood signals for
calcification imaging. Intralipid and chicken breast phantoms
embedded with different-sized HA particles were imaged to
verify the achievable imaging depth of the custom-built system
for the visualization of calcifications. We further showed that the
PA spectroscopic technique is capable of differentiating HAs
from blood. Finally, the noise-equivalent penetration depth of
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the system for visualizing HAs in human breast is further cal-
culated according to the PA signal intensity obtained in phantom
studies and the acoustic and optical attenuation coefficients of
human breast from the literature.
2 Materials and Methods
2.1 Measurement of PA Spectrum of HA Particles
To select an optimal excitation wavelength of HAs for the fol-
lowing PA array imaging experiments, PA signals from HA par-
ticles at different optical wavelengths (i.e., PA spectrum of HA
particles) were measured with a 5-MHz dark-field backward-
mode confocal PAM setup.5 The PAM setup was equipped
with a photodiode, while the array imaging setup used for
the following imaging experiments did not have the photodiode
channel. The photodiode signals could be used to compensate
for PA signal variations caused by laser-energy fluctuations and
differences in laser output at different wavelengths. For a
spectroscopic study, such compensation is necessary; therefore,
PAM was utilized here instead of the array setup. An optical
parametric oscillator (Surlite OPO Plus, Continuum, USA)
pumped by a frequency-doubled Q-switched Nd∶YAG laser
(Surlite II-10, Continuum, USA) was employed to provide
laser pulses with a pulse width of ∼4 ns and a pulse repetition
rate of 10 Hz. Laser energy was delivered by a 1-mm multimode
fiber. The fiber tip was coaxially positioned with a convex lens,
an axicon, a plexiglass mirror, and a 5-MHz focused ultrasonic
transducer (V310-SM, Olympus, USA) on an optical bench,
which created dark-field illumination and made the light confo-
cal with the ultrasonic transducer. The optical bench was fixed
on a three-dimensional precision translation stage, upon which
the x and y axes were motorized and the z axis could be man-
ually adjusted with a micrometer. The PA signals received by the
5-MHz transducer were preamplified by a low-noise amplifier
(AU-3A-0110, Miteq, USA), cascaded to an ultrasonic pulser/
receiver (5073 PR, Olympus, USA), low-pass filtered, digitized
by a PC-based 14-bit analog-to-digital card (CompuScope
14200, GaGe, USA), sampled at 200 MHz, and then recorded
onto a PC. Before any further signal processing, signals from a
photodiode (DET36A/M, Thorlabs, USA) were used to com-
pensate for PA signal variations caused by laser-energy instabil-
ity and differences in laser output at different wavelengths.
An NIR window between 670 and 850 nm was selected due
to the relatively lower optical absorption of hemoglobin, lipids,
and water in this window, and thus deeper penetration could be
potentially achieved.3 The granulated HA particles were pre-
pared with commercially available HA powder (Plasma
Biotal Ltd., Tideswell, UK). The HA powder was sintered at
900 to 1000°C for 2 to 4 h in a dry air atmosphere to form poly-
crystalline calcification particles. The typical size of breast cal-
cifications is between 0.3 and 1.0 mm.9 Therefore, six
granulated HA particles with the size of about 0.5 to 1 mm
were used. The particles were fixed on a clear porcine gel phan-
tom during the measurement by a thin layer of porcine gel, and
1000 measurements were taken at each wavelength for each par-
ticle in order to improve the signal-to-noise ratio (SNR) and fur-
ther reduce the effects of laser energy fluctuation.
2.2 Experimental Setup of PA Array Imaging
Based on a medical ultrasound array imaging platform, a PA
array imaging system was built to verify the achievable imaging
depth for visualizing calcifications. The array imaging system
could provide the real-time imaging capability and potentially
extend the depth of focus with dynamic receive focusing tech-
nique. In addition, it was inherently compatible with clinical
ultrasound, thus enabling PA/ultrasound dual modal imaging.
The PA array imaging system was used here for deep tissue im-
aging of calcifications. The experimental setup was as illustrated
in Fig. 1. The laser utilized here was the same as the one used for
the PA spectrum measurements. A 5-MHz and 128-element
medical ultrasound linear array with a fractional bandwidth
of 71% (AT5L40B, Broadsound Corporation, Taiwan) was
used for PA signal detection. The −6-dB axial and lateral res-
olutions of this PA array imaging system were 0.54 and 0.35 mm
at the depth of 3 cm, respectively. The detected PA signals
were acquired and digitized with a PC-based ultrasound array
data acquisition system—Verasonics V-1 (Verasonics Inc.,
Redmond, Washington). Image reconstruction was done on
the control PC where a delay-and-sum beam-forming algorithm
was employed. To improve image contrast, coherence factor
weighting10 was also applied. Side-way illumination, instead
of the dark-field geometry used in PAM, was adopted here
because it was easier to implement, providing a relatively uni-
form optical fluence over the imaging plane of the array trans-
ducer. Two types of phantoms—intralipid and chicken breast
phantoms—were used for this study. The intralipid phantom
was prepared using gelatin (gelatin, G2500-1KG, Sigma-
Aldrich, St. Louis, Missouri) as the matrix with the addition
of 1% of intralipid (Lipovenoes 20%) as an optical scatterer.
A double-integrating-sphere setup along with the inverse adding
doubling algorithm was used to determine the optical absorption
coefficient (μa) and reduced optical scattering coefficient (μ 0s) of
the phantoms.11 The study objects (e.g., HA particles and blood-
loaded tubes) were positioned so that their optical and acoustic
depths were both ∼3 cm in the phantoms, as illustrated in Fig. 1.
Note that in the following phantom experiments, signal averag-
ing of 20 times was performed to improve the SNR.
Fig. 1 Illustration of experimental setup of PA array imaging. The opti-
cal depth indicated by the horizontal double-arrowed dotted line rep-
resents the distance from the laser illumination surface to the imaging
plane; the acoustic depth indicated by the vertical double-arrowed solid
line is the distance from the transducer surface to the imaging objects in
the imaging plane. The dashed parallelogram illustrates the imaging
plane beneath the array transducer.
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3 Results and Discussions
Figure 2(a) shows the normalized PA signals measured from six
granulated HA particles at excitation wavelengths ranging from
670 to 850 nm. The PA signal of the HA particles showed a
tendency to decrease with a longer optical wavelength, which
is substantially consistent with the reported optical absorption
spectrum of HA.12,13 The PA spectrum of HA particles was fur-
ther compared with that of blood—a dominant optical absorber
in human breast tissue. Figure 2(b) shows the calculated PA sig-
nal ratios of HA to blood with different oxygen saturation (SO2)
as a function of wavelength. This figure was plotted based on the
compiled molar extinction spectral data of oxy- and deoxy-
hemoglobin provided by Oregon Medical Laser Center
(http://omlc.ogi.edu), an assumed typical hemoglobin concen-
tration for whole blood of 150 gHb∕liter, and the proportion-
ality of PA signals from blood to absorption coefficients of
blood with different SO2.
14 Only blood with SO2 ranging from
70 to 100% was considered here because the average SO2 of
arterial and venous blood is >95% and 70 to 75%, respectively.
From Fig. 2(a) and 2(b), we ascertained that around 700 nm,
stronger PA signals of HA particles and a higher signal ratio
of HA to blood were obtained. In addition, our laser output
was more stable with higher energy at 700 nm. Therefore,
the wavelength of 700 nm was selected as the excitation wave-
length for the array imaging experiments.
An ultrasound speckle-generating intralipid phantom with a
blood-loaded tube and different-sized HA particle embedded
was imaged first. The measured μa and μ 0s of the intralipid phan-
tom were 0.06 and 5.09 cm−1 at 700 nm, respectively, which are
close to the reported data on postmenopausal breast tissues at
700 nm.15 A blood-loaded tube with a 0.25-mm inner diameter
and HA particles with about 1.0 and 0.5 mm size were placed in
a row within the imaging plane, as illustrated in Fig. 1. The
depths of all the HA particles from the transducer surface
(i.e., acoustic depth in Fig. 1) and from the laser illumination
surface (i.e., optical depth in Fig. 1) were approximately
3.0 cm, respectively. The laser exposure on the sample surface
was about 18 mJ∕cm2 at 700 nm, which was well within the
American National Standards Institute safety limit of
20 mJ∕cm2. Figure 3(a) depicts the ultrasound B-mode image
used as a reference to locate the imaging objects. Figure 3(b)
represents the PA B-mode image acquired at a wavelength of
700 nm, revealing the high contrast feature of PA imaging
compared with pulse-echo ultrasound. From left to right are
cross-sections of the blood-loaded tube and 1.0- and 0.5-mm
HA particles positioned at the depth of ∼3 cm, respectively.
The estimated SNRs for the blood-loaded tube, the 1.0-mm
Fig. 2 (a) Amplitude of measured PA signals as a function of wavelength from six HA particles with sizes ranging from 0.5 to 1 mm. The error bar is the
standard deviation of the six measurements of the HA particles. (b) Calculated PA signal ratios of HA to blood with different SO2 between 670 and
850 nm. a.u., arbitrary unit.
Fig. 3 Ultrasound and PA B-mode images of the cross-sectional blood-loaded tube, 1.0-mm HA particle, and 0.5-mm HA particle, which are all
displayed on a 40-dB dynamic range. (a) Ultrasound B-mode image, (b) PA B-mode image acquired at the wavelength of 700 nm, (c) PA B-
mode image acquired at the wavelength of 800 nm. S1, blood-loaded tube; S2, 1.0-mm HA particle; S3, 0.5-mm HA particle. Note that in (b)
and (c), the PA signals were normalized by the peak intensity of S1.
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HA particle, and the 0.5-mm HA particle were 43.2, 35.7, and
29.6 dB, respectively, indicating that deeper penetration can be
achieved. The SNR was defined as the peak of the PA signals
obtained from the objects divided by the root mean square of the
background signals. Figure 3(c) illustrates the PA B-mode
image acquired at a wavelength of 800 nm. In Fig. 3(b) and
3(c), the PA signals were normalized by the peak signal inten-
sities of the blood-loaded tube at 700 and 800 nm, respectively.
In addition, the averaged laser exposure at 700 and 800 nm was
carefully checked and kept constant during the experiments due
to the lack of a photodiode channel in the array imaging system
for compensation of the PA signal variation caused by laser
energy fluctuation. The signals of HA particles decreased rela-
tive to those in Fig. 3(b). This trend follows the spectral curves
portrayed in Fig. 2(b), which were also normalized to the blood
signals. These results indicated the feasibility of differentiating
the HA signals from blood by the PA spectroscopic technique.
In addition, a chicken breast phantom experiment was
performed to further evaluate the achievable imaging depth
of the system for visualizing calcifications in real tissues. The
measured μa and μ 0s of the chicken breast phantom were
0.25 and 3.26 cm−1, respectively, at 700 nm. Three HA particles
were embedded in a row within the imaging plane. Figure 4(a)
shows the PA B-mode image of the chicken breast phantom. The
HA particles of all sizes could be identified due to the high con-
trast and speckle-free PA image. From left to right, HA particle
sizes were 0.5, 1.0, and 0.5 mm, respectively. The estimated
SNRs of the particles from left to right were 14.1, 19.6, and
15.5 dB, respectively. Compared with those in the intralipid
phantom, the lower SNRs of HA particles in the chicken breast
phantom were caused by the higher effective optical attenuation
coefficient of the chicken breast phantom. Figure 4(b) illustrates
the ultrasound B-mode image coregistered with the PA image in
Fig. 4(a). The threshold used for the coregistration was 25 dB. In
the ultrasound image, HA particles were barely identified
because of speckle noises and hyperechoic spots from chicken
breast tissues. The coregistration of the PA and ultrasound
images was helpful in localizing the HA particles within a struc-
tural ultrasound background image.
The maximum achievable depth for imaging HAs in human
breast is derived as follows. From the μa and μ 0s of the exper-
imental chicken breast, its calculated optical attenuation at
700 nm is 7.0 dB∕cm and its reported acoustic attenuation is
about 2.0 dB∕cm at 5 MHz, which is the center frequency of
the used array transducer.16 The two-way PA attenuation of
the chicken breast is the summation of the optical and acoustic
attenuation, which is 9.0 dB∕cm in this case. Without attenua-
tion, the SNR of the 0.5-mm HA particle would have been
41 dB. Similarly, according to the acoustic attenuation [i.e.,
8.4 dB∕cm at 5 MHz (Ref. 17)] and the reported μa and μ 0s
of the human breast,11 the resultant two-way PA attenuation
is 14.0 dB∕cm for premenopausal breast and 11.7 dB∕cm for
postmenopausal breast. Therefore, the calculated noise-equiva-
lent penetration depth for 0.5-mm HA is about 2.9 cm in pre-
menopausal breast and about 3.5 cm in a postmenopausal breast,
which is suitable for clinical applications because breast calci-
fications are located mostly at the depth of 0.6 to 3.0 cm.18 As
for the mechanism of the HA signal generation, the magnitude
of the HA signal is contributed to from both μa and Grüneisen
coefficient.19 It is found that the μa of HA [i.e., 0.75 cm−1
(Ref. 9)] is smaller than that of whole blood (i.e., ∼3.97 cm−1)
by about five times at the wavelength of 700 nm, while the
Grüneisen coefficients of whole blood and dental enamel, in
which at least 96% is HA, are about 0.25 and 1.4, respec-
tively.13,15 Presumably, the Grüneisen coefficient contributes
greatly to the HA signal.
4 Conclusions
In summary, we have successfully demonstrated that by using a
medical ultrasound array imaging platform at an optimal wave-
length of 700 nm, the HA calcification particles of size 0.5 mm
can be visualized at a depth of 3 cm in a chicken breast phantom
with an SNR of 14.1 dB. Prior data from the literature suggests
that with our 5-MHz PA array imaging system, we should expect
a penetration depth of about 2.9 to 3.5 cm for visualization of
calcifications in human breast. This depth coverage is clinically
relevant as most calcifications occur at this depth. It should be
noted that this study does not exclude the value of PA imaging of
breast tumor vascularization—also an important feature of
breast cancer. PA visualization of microcalcifications without
interference from other absorbers, such as blood, could provide
additional value to conventional ultrasound- and also angiogen-
esis-contrast-based PA breast imaging. We demonstrated the
feasibility that HA can be differentiated from blood by using
the PA spectroscopic technique. The penetration depth and
specificity can be further improved by introducing NIR fluores-
cent optical contrast agents targeting HA.20 In addition, our
results suggest that PA/ultrasound dual modal imaging may
Fig. 4 PA and PA/ultrasound coregistered B-mode images of a chicken breast phantomwith HA particles embedded. (a) PA B-mode images acquired at
the wavelength of 700 nm and displayed over a 25-dB dynamic range. (b) PA/ultrasound coregistered B-mode image, where the ultrasound image is
displayed over a 50-dB dynamic range. S1, 0.5-mm HA particle; S2, 1.0-mm HA particle; S3, 0.5-mm HA particle.
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enhance the identification of anatomical locations of calcifica-
tions, which complements x-ray mammography typically for
dense breast21 and breast ultrasound. Overall, PA imaging cor-
egistered with breast ultrasound shows great promise as a real-
time diagnosis and biopsy guidance tool for visualization of
breast calcifications.
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